XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Jun. 30, 2021   13,609      
Beginning balance at Jun. 30, 2021 $ 36,807 $ 1 $ 129,048 $ (92,346) $ 104
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 645   645    
Exercise of options (in shares)   30      
Exercise of options 133   133    
Common stock issued under equity award plans (in shares)   49      
Common stock issued under equity award plans 0        
Shares canceled or surrendered as payment of tax withholding and other (in shares)   (19)      
Shares canceled or surrendered as payment of tax withholding and other (139)   (139)    
Repurchase of company stock (in shares)   (460)      
Repurchase of company stock (3,492)     (3,492)  
Common stock issued under employee stock purchase plan (in shares)   27      
Common stock issued under employee stock purchase plan 175   175    
Currency translation adjustment (135)       (135)
Net income (loss) 3,316     3,316  
Ending balance (in shares) at Sep. 30, 2021   13,236      
Ending balance at Sep. 30, 2021 37,310 $ 1 129,862 (92,522) (31)
Beginning balance (in shares) at Jun. 30, 2021   13,609      
Beginning balance at Jun. 30, 2021 $ 36,807 $ 1 129,048 (92,346) 104
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued under employee stock purchase plan (in shares) 68        
Net income (loss) $ 4,536        
Ending balance (in shares) at Mar. 31, 2022   12,577      
Ending balance at Mar. 31, 2022 34,031 $ 1 130,714 (96,184) (500)
Beginning balance (in shares) at Jun. 30, 2021   13,609      
Beginning balance at Jun. 30, 2021 $ 36,807 $ 1 129,048 (92,346) 104
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Repurchase of company stock (in shares) (1,200)        
Ending balance (in shares) at Jun. 30, 2022 12,493 12,493      
Ending balance at Jun. 30, 2022 $ 31,516 $ 1 131,075 (98,437) (1,123)
Beginning balance (in shares) at Sep. 30, 2021   13,236      
Beginning balance at Sep. 30, 2021 37,310 $ 1 129,862 (92,522) (31)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 755   755    
Common stock issued under equity award plans (in shares)   67      
Common stock issued under equity award plans 0        
Shares canceled or surrendered as payment of tax withholding and other (in shares)   (5)      
Shares canceled or surrendered as payment of tax withholding and other (31)   (31)    
Repurchase of company stock (in shares)   (454)      
Repurchase of company stock (3,154)     (3,154)  
Currency translation adjustment (179)       (179)
Net income (loss) 79     79  
Ending balance (in shares) at Dec. 31, 2021   12,844      
Ending balance at Dec. 31, 2021 34,780 $ 1 130,586 (95,597) (210)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation (38)   (38)    
Common stock issued under equity award plans (in shares)   23      
Common stock issued under equity award plans 0        
Shares canceled or surrendered as payment of tax withholding and other (in shares)   (5)      
Shares canceled or surrendered as payment of tax withholding and other (31)   (31)    
Repurchase of company stock (in shares)   (326)      
Repurchase of company stock $ (1,728)     (1,728)  
Common stock issued under employee stock purchase plan (in shares) 41 41      
Common stock issued under employee stock purchase plan $ 197   197    
Currency translation adjustment (290)       (290)
Net income (loss) 1,141     1,141  
Ending balance (in shares) at Mar. 31, 2022   12,577      
Ending balance at Mar. 31, 2022 $ 34,031 $ 1 130,714 (96,184) (500)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Repurchase of company stock (in shares) (300)        
Ending balance (in shares) at Jun. 30, 2022 12,493 12,493      
Ending balance at Jun. 30, 2022 $ 31,516 $ 1 131,075 (98,437) (1,123)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 602   602    
Common stock issued under equity award plans (in shares)   48      
Common stock issued under equity award plans 0        
Shares canceled or surrendered as payment of tax withholding and other (in shares)   (17)      
Shares canceled or surrendered as payment of tax withholding and other (72)   (72)    
Common stock issued under employee stock purchase plan (in shares)   36      
Common stock issued under employee stock purchase plan 121   121    
Cash dividends (377)     (377)  
Currency translation adjustment (510)       (510)
Net income (loss) 610     610  
Ending balance (in shares) at Sep. 30, 2022   12,560      
Ending balance at Sep. 30, 2022 $ 31,890 $ 1 131,726 (98,204) (1,633)
Beginning balance (in shares) at Jun. 30, 2022 12,493 12,493      
Beginning balance at Jun. 30, 2022 $ 31,516 $ 1 131,075 (98,437) (1,123)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Repurchase of company stock (in shares) 0        
Common stock issued under employee stock purchase plan (in shares) 76        
Net income (loss) $ 574        
Ending balance (in shares) at Mar. 31, 2023 12,771 12,771      
Ending balance at Mar. 31, 2023 $ 33,442 $ 1 133,424 (99,004) (979)
Beginning balance (in shares) at Sep. 30, 2022   12,560      
Beginning balance at Sep. 30, 2022 31,890 $ 1 131,726 (98,204) (1,633)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 823   823    
Common stock issued under equity award plans (in shares)   152      
Common stock issued under equity award plans 0        
Shares canceled or surrendered as payment of tax withholding and other (in shares)   (5)      
Shares canceled or surrendered as payment of tax withholding and other (19)   (19)    
Cash dividends (381)     (381)  
Currency translation adjustment 640       640
Net income (loss) (1,058)     (1,058)  
Ending balance (in shares) at Dec. 31, 2022   12,707      
Ending balance at Dec. 31, 2022 31,895 $ 1 132,530 (99,643) (993)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 817   817    
Common stock issued under equity award plans (in shares)   40      
Common stock issued under equity award plans 0        
Shares canceled or surrendered as payment of tax withholding and other (in shares)   (14)      
Shares canceled or surrendered as payment of tax withholding and other $ (54)   (54)    
Repurchase of company stock (in shares) 0        
Common stock issued under employee stock purchase plan (in shares) 40 38      
Common stock issued under employee stock purchase plan $ 131   131    
Cash dividends (383)     (383)  
Currency translation adjustment 14       14
Net income (loss) $ 1,022     1,022  
Ending balance (in shares) at Mar. 31, 2023 12,771 12,771      
Ending balance at Mar. 31, 2023 $ 33,442 $ 1 $ 133,424 $ (99,004) $ (979)